Study of a new drug-releasing stent for heart arteries
Part of Heart & circulation clinical trials.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have symptoms or test results showing your heart isn't getting enough blood, and you need a stent.
- The narrowed artery in your heart can be treated with the study stent.
- You agree to the study plan and sign a consent form.
- You are not allergic to any of these: heparin, aspirin, clopidogrel, sirolimus, or contrast dye (if you are allergic to contrast dye, you can still join if your doctor can manage it).
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug-coated stent (GENOSS® DES) for people with blockages in multiple heart arteries. It aims to see how safe and effective the stent is for these patients.
This trial tests whether a shorter course of dual antiplatelet therapy (two blood thinners) is safe and effective for people who have received a GENOSS stent for coronary artery disease. It aims to reduce the risk of bleeding while still preventing heart attacks.
This study tests whether taking two blood thinners for one year after getting a special GENOSS stent is safe and works well for people with coronary artery disease, especially if the stent placement was complex. The goal is to prevent blood clots and keep your artery open.
This trial tests a special stent (OSFIT) in people with a blockage near the start of a coronary artery. The goal is to see if the stent works well for this specific location.
This trial is testing a new type of stent (a small tube that props open a narrowed heart artery) coated with a medicine called everolimus to keep the artery open. The study wants to see if the stent is safe and works well for people with coronary artery disease, which is narrowing of the heart's blood vessels.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.